West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
358.24
-4.20 (-1.16%)
At close: Jul 17, 2026, 4:00 PM EDT
365.40
+7.16 (2.00%)
After-hours: Jul 17, 2026, 7:11 PM EDT
WST Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, WST stock has a consensus rating of "Strong Buy" and an average price target of $374.14. The average 1-year stock price forecast is 4.44% higher than the current stock price, while the lowest is $310 (-13.47%) and the highest is $410 (+14.45%).
Price Target: $374.14 (+4.44%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for WST stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 10 | 10 | 10 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $365 → $410 | Buy | Maintains | $365 → $410 | +14.45% | Jul 15, 2026 |
| Exane BNP Paribas | Exane BNP Paribas | Buy Initiates $447 | Buy | Initiates | $447 | +24.78% | Jul 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $325 → $365 | Hold | Reiterates | $325 → $365 | +1.89% | Jul 9, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $390 → $410 | Buy | Maintains | $390 → $410 | +14.45% | Jul 6, 2026 |
| KeyBanc | KeyBanc | Buy Maintains $350 → $390 | Buy | Maintains | $350 → $390 | +8.87% | Jul 2, 2026 |
Financial Forecast
Revenue This Year
3.33B
from 3.07B
Increased by 8.42%
Revenue Next Year
3.54B
from 3.33B
Increased by 6.13%
EPS This Year
8.62
from 7.29
Increased by 18.19%
EPS Next Year
9.62
from 8.62
Increased by 11.65%
EPS and Forward PE are based on non-GAAP adjusted numbers.